Patents Assigned to DexCom, Inc.
  • Patent number: 8774888
    Abstract: Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.
    Type: Grant
    Filed: January 20, 2010
    Date of Patent: July 8, 2014
    Assignee: DexCom, Inc.
    Inventors: Apurv Ullas Kamath, Paul V. Goode, Jr., James H. Brauker, James Patrick Thrower
  • Patent number: 8771187
    Abstract: Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.
    Type: Grant
    Filed: May 31, 2011
    Date of Patent: July 8, 2014
    Assignee: DexCom, Inc.
    Inventors: Paul V. Goode, Jr., James H. Brauker, Apurv U. Kamath
  • Patent number: 8774886
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into a host's peripheral vein or artery.
    Type: Grant
    Filed: October 4, 2006
    Date of Patent: July 8, 2014
    Assignee: Dexcom, Inc.
    Inventors: Mark Brister, Sean Saint, Vance Swanson, Nelson Quintana
  • Publication number: 20140188402
    Abstract: Systems and methods for processing sensor data and end of life detection are provided. In some embodiments, a method for determining the end of life of a continuous analyte sensor includes evaluating a plurality of risk factors using an end of life function to determine an end of life status of the sensor and providing an output related to the end of life status of the sensor. The plurality of risk factors may be selected from the list including the number of days the sensor has been in use, whether there has been a decrease in signal sensitivity, whether there is a predetermined noise pattern, whether there is a predetermined oxygen concentration pattern, and error between reference BG values and EGV sensor values.
    Type: Application
    Filed: January 3, 2013
    Publication date: July 3, 2014
    Applicant: Dexcom, Inc.
    Inventors: Arturo Garcia, Naresh C. Bhavaraju, Hari Hampapuram, Apurv Ullas Kamath, Aarthi Mahalingam, Dmytro Sokolovskyy, Stephen J. Vanslyke
  • Publication number: 20140182350
    Abstract: Systems and methods for processing sensor data and end of life detection are provided. In some embodiments, a method for determining the end of life of a continuous analyte sensor includes evaluating a plurality of risk factors using an end of life function to determine an end of life status of the sensor and providing an output related to the end of life status of the sensor. The plurality of risk factors may be selected from the list including the number of days the sensor has been in use, whether there has been a decrease in signal sensitivity, whether there is a predetermined noise pattern, whether there is a predetermined oxygen concentration pattern, and error between reference BG values and EGV sensor values.
    Type: Application
    Filed: January 3, 2013
    Publication date: July 3, 2014
    Applicant: DexCom, Inc.
    Inventors: Naresh C. Bhavaraju, Arturo Garcia, Hari Hampapuram, Apurv Ullas Kamath, Aarthi Mahalingam, Dmytro Sokolovskyy, Stephen J. Vanslyke
  • Publication number: 20140187890
    Abstract: Methods and apparatus, including computer program products, are provided for remote monitoring. In some example implementations, there is provided a method. The method may include receiving, at a remote monitor, a notification message representative of an event detected, by a server, from analyte sensor data obtained from a receiver monitoring an analyte state of a host; presenting, at the remote monitor, the notification message to activate the remote monitor, wherein the remote monitor is configured by the server to receive the notification message to augment the receiver monitoring of the analyte state of the host; accessing, by the remote monitor, the server, in response to the presenting of the notification message; and receiving, in response to the accessing, information including at least the analyte sensor data. Related systems, methods, and articles of manufacture are also disclosed.
    Type: Application
    Filed: December 30, 2013
    Publication date: July 3, 2014
    Applicant: DexCom, Inc.
    Inventors: Michael Robert Mensinger, Eric Cohen, Phil Mayou, Eli Reihman, Katherine Yerre Grubstein, Rian Draeger, Angela Marie Traven
  • Publication number: 20140184422
    Abstract: Methods and apparatus, including computer program products, are provided for remote monitoring. In some example implementations, there is provided a method. The method may include receiving, at a remote monitor, a notification message representative of an event detected, by a server, from analyte sensor data obtained from a receiver monitoring an analyte state of a host; presenting, at the remote monitor, the notification message to activate the remote monitor, wherein the remote monitor is configured by the server to receive the notification message to augment the receiver monitoring of the analyte state of the host; accessing, by the remote monitor, the server, in response to the presenting of the notification message; and receiving, in response to the accessing, information including at least the analyte sensor data. Related systems, methods, and articles of manufacture are also disclosed.
    Type: Application
    Filed: March 15, 2013
    Publication date: July 3, 2014
    Applicant: DexCom, Inc.
    Inventors: Michael Robert Mensinger, Eric Cohen, Phil Mayou, Eli Reihman, Katherine Yerre Grubstein, Rian Draeger, Angela Marie Traven
  • Publication number: 20140180049
    Abstract: Systems and methods for dynamically and intelligently estimating analyte data from a continuous analyte sensor, including receiving a data stream, selecting one of a plurality of algorithms, and employing the selected algorithm to estimate analyte values. Additional data processing includes evaluating the selected estimative algorithms, analyzing a variation of the estimated analyte values based on statistical, clinical, or physiological parameters, comparing the estimated analyte values with corresponding measure analyte values, and providing output to a user. Estimation can be used to compensate for time lag, match sensor data with corresponding reference data, warn of upcoming clinical risk, replace erroneous sensor data signals, and provide more timely analyte information encourage proactive behavior and preempt clinical risk.
    Type: Application
    Filed: February 25, 2014
    Publication date: June 26, 2014
    Applicant: DexCom, Inc.
    Inventors: James H. Brauker, Victoria E. Carr-Brendel, Paul V. Goode, Apurv Ullas Kamath, James Patrick Thrower, Ben Xavier
  • Patent number: 8761856
    Abstract: Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: June 24, 2014
    Assignee: DexCom, Inc.
    Inventors: Paul V. Goode, James H. Brauker, Apurv Ullas Kamath, James Patrick Thrower
  • Publication number: 20140161969
    Abstract: The present invention relates generally to devices for measuring an analyte in a host. More particularly, the present invention relates to devices for measurement of glucose in a host that incorporate a cellulosic-based resistance domain.
    Type: Application
    Filed: February 14, 2014
    Publication date: June 12, 2014
    Applicant: DexCom, Inc.
    Inventors: James R. Petisce, Kum Ming Woo, Victor Ha, Melissa A. Nicholas
  • Patent number: 8747315
    Abstract: Systems and methods for dynamically and intelligently estimating analyte data from a continuous analyte sensor, including receiving a data stream, selecting one of a plurality of algorithms, and employing the selected algorithm to estimate analyte values. Additional data processing includes evaluating the selected estimative algorithms, analyzing a variation of the estimated analyte values based on statistical, clinical, or physiological parameters, comparing the estimated analyte values with corresponding measure analyte values, and providing output to a user. Estimation can be used to compensate for time lag, match sensor data with corresponding reference data, warn of upcoming clinical risk, replace erroneous sensor data signals, and provide more timely analyte information encourage proactive behavior and preempt clinical risk.
    Type: Grant
    Filed: September 23, 2009
    Date of Patent: June 10, 2014
    Assignee: DexCom. Inc.
    Inventors: James H. Brauker, Victoria Carr-Brendel, Paul V. Goode, Apurv U. Kamath, James P. Thrower, Ben Xavier
  • Patent number: 8750955
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 2, 2009
    Date of Patent: June 10, 2014
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Steve Masterson, J. Michael Dobbles, Michael Robert Mensinger, Sean Saint, Apurv Ullas Kamath, James Brauker, James Patrick Thrower
  • Patent number: 8744546
    Abstract: The present invention relates generally to devices for measuring an analyte in a host. More particularly, the present invention relates to devices for measurement of glucose in a host that incorporate a cellulosic-based resistance domain.
    Type: Grant
    Filed: April 28, 2006
    Date of Patent: June 3, 2014
    Assignee: DexCom, Inc.
    Inventors: James R. Petisce, Kum Ming Woo, Victor Ha, Melissa Nicholas
  • Publication number: 20140148667
    Abstract: Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species.
    Type: Application
    Filed: January 30, 2014
    Publication date: May 29, 2014
    Applicant: DexCom, Inc.
    Inventors: Robert Boock, Monica Rixman Swinney, Huashi Zhang, Michael J. Estes, Kristina Lawrence
  • Publication number: 20140148666
    Abstract: Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species.
    Type: Application
    Filed: January 30, 2014
    Publication date: May 29, 2014
    Applicant: DexCom, Inc.
    Inventors: Robert Boock, Monica Rixman Swinney, Huashi Zhang, Michael J. Estes, Kristina Lawrence
  • Publication number: 20140142405
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: January 24, 2014
    Publication date: May 22, 2014
    Applicant: DexCom, Inc.
    Inventors: Mark Brister, Paul V. Neale, James R. Petisce, James Thrower, Sean Saint, John Nolting
  • Patent number: 8731630
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: March 22, 2010
    Date of Patent: May 20, 2014
    Assignee: DexCom, Inc.
    Inventors: Apurv Ullas Kamath, James Brauker, J. Michael Dobbles
  • Patent number: 8721545
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: March 22, 2010
    Date of Patent: May 13, 2014
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Paul V. Neale, Sean Saint, James Patrick Thrower, Thomas F. McGee, Daniel Shawn Codd, David Michael Petersen, Daniel S. Kline
  • Publication number: 20140123893
    Abstract: Described here are embodiments of processes and systems for the continuous manufacturing of implantable continuous analyte sensors. In some embodiments, a method is provided for sequentially advancing an elongated conductive body through a plurality of stations, each configured to treat the elongated conductive body. In some of these embodiments, one or more of the stations is configured to coat the elongated conductive body using a meniscus coating process, whereby a solution formed of a polymer and a solvent is prepared, the solution is continuously circulated to provide a meniscus on a top portion of a vessel holding the solution, and the elongated conductive body is advanced through the meniscus. The method may also comprise the step of removing excess coating material from the elongated conductive body by advancing the elongated conductive body through a die orifice.
    Type: Application
    Filed: January 15, 2014
    Publication date: May 8, 2014
    Applicant: DexCom, Inc.
    Inventors: Robert Boock, Jeff Jackson, Huashi Zhang, Jason Mitchell
  • Patent number: D704632
    Type: Grant
    Filed: June 18, 2013
    Date of Patent: May 13, 2014
    Assignee: DexCom, Inc.
    Inventors: Peter On, Bryan Calo, Chris Ross, Eli Reihman, Katherine Yerre Grubstein